Acurx Pharmaceuticals, Inc.
ACXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001736243
No open-market purchases or sales by Acurx Pharmaceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $185.5K in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Acurx Pharmaceuticals, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −15 vs. Q2 2025
- Shares held
- 63.4K
- −67.1K (−51.4%) vs. Q2 2025Converted for a 1-for-20 split
- Total value
- $241.5K
- −$1.09M (−81.8%) vs. Q2 2025
- New holders
- 3
- 8 more added
- Sold out
- 18
- 2 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACXP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $185.5K |
| Q1 2026 | 21 | $674.2K |
| Q4 2025 | 18 | $345.2K |
| Q3 2025 | 16 | $241.5K |
| Q2 2025 | 32 | $1.33M |
| Q1 2025 | 24 | $1.36M |
| Q4 2024 | 26 | $1.15M |
| Q3 2024 | 22 | $2.41M |
| Q2 2024 | 25 | $2.71M |
| Q1 2024 | 26 | $3.05M |
| Q4 2023 | 23 | $4.18M |
| Q3 2023 | 18 | $1.32M |
| Q2 2023 | 13 | $3.94M |
| Q1 2023 | 12 | $1.86M |
| Q4 2022 | 14 | $5.27M |
| Q3 2022 | 14 | $4.66M |
| Q2 2022 | 12 | $1.43M |
| Q1 2022 | 9 | $1.15M |
| Q4 2021 | 11 | $455.3K |
| Q3 2021 | 8 | $332.0K |
| Q2 2021 | 3 | $163.0K |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Acurx Pharmaceuticals, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Prospect Financial Services LLC | 19,883 | $85.3K | 0.05% | +5,044+34.0% | AddedConverted for a 1-for-20 split |
| Susquehanna International Group, LLP | 16,815 | $72.1K | 0.00% | +13,328+382.2% | AddedConverted for a 1-for-20 split |
| Sabby Management, LLC | 8,705 | $37.3K | 0.19% | +4,610+112.6% | AddedConverted for a 1-for-20 split |
| Morgan Stanley | 5,310 | $22.8K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| NBC Securities, Inc. | 1,500 | $6.43K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| GPS Wealth Strategies Group, LLC | 1,225 | $5.26K | 0.00% | +50+4.3% | AddedConverted for a 1-for-20 split |
| Tower Research Capital LLC (TRC) | 1,077 | $4.62K | 0.00% | +869+418.4% | AddedConverted for a 1-for-20 split |
| Advisor Group Holdings, Inc. | 7,824 | $3.50K | 0.00% | +7,301+1,397.1% | AddedConverted for a 1-for-20 split |
| Citigroup Inc | 453 | $1.94K | 0.00% | +453 | New |
| Group One Trading, L.P. | 298 | $1.28K | 0.00% | −382−56.2% | ReducedConverted for a 1-for-20 split |
| Bank of America Corp | 71 | $304 | 0.00% | +4+5.2% | AddedConverted for a 1-for-20 split |
| BlackRock, Inc. | 60 | $257 | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Advisory Services Network, LLC | 59 | $253 | 0.00% | +59 | New |
| Wealthspire Advisors, LLC | 15 | $65 | 0.00% | +15 | New |
| SBI Securities Co., Ltd. | 13 | $56 | 0.00% | −1−8.5% | ReducedConverted for a 1-for-20 split |
| Cornerstone Planning Group LLC | 67 | – | – | +59+702.4% | AddedConverted for a 1-for-20 split |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −53,927−100.0% | Sold outConverted for a 1-for-20 split |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −7,320−100.0% | Sold outConverted for a 1-for-20 split |
| Vanguard Group Inc | 0 | $0 | 0.00% | −7,277−100.0% | Sold outConverted for a 1-for-20 split |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −4,389−100.0% | Sold outConverted for a 1-for-20 split |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −4,250−100.0% | Sold outConverted for a 1-for-20 split |
| O'Brien Greene & Co. Inc | 0 | $0 | 0.00% | −3,000−100.0% | Sold outConverted for a 1-for-20 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −2,756−100.0% | Sold outConverted for a 1-for-20 split |
| Vanguard Capital Wealth Advisors | 0 | $0 | 0.00% | −2,300−100.0% | Sold outConverted for a 1-for-20 split |
| ACT Advisors, LLC. | 0 | $0 | 0.00% | −2,298−100.0% | Sold outConverted for a 1-for-20 split |
| State Street Corp | 0 | $0 | 0.00% | −2,173−100.0% | Sold outConverted for a 1-for-20 split |
| UBS Group AG | 0 | $0 | 0.00% | −1,938−100.0% | Sold outConverted for a 1-for-20 split |
| XTX Topco Ltd | 0 | $0 | 0.00% | −1,884−100.0% | Sold outConverted for a 1-for-20 split |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −1,401−100.0% | Sold outConverted for a 1-for-20 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −1,364−100.0% | Sold outConverted for a 1-for-20 split |
| Wealthcare Advisory Partners LLC | 0 | $0 | 0.00% | −577−100.0% | Sold outConverted for a 1-for-20 split |
| Baader Bank INC | 0 | $0 | 0.00% | −820−100.0% | Sold outConverted for a 1-for-20 split |
| Quartz Partners, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold outConverted for a 1-for-20 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −344−100.0% | Sold outConverted for a 1-for-20 split |
| Semmax Financial Advisors Inc. | – | – | – | – | Not filed |